Infections covered here are cryptococcal meningitis and cryptococcal pneumonia. The Fungi responsible are usually Cryptococcus neoformans and in non-immunocompromised people, C. gattii  is proportionately more common.

Causes subacute meningitis with increasing symptoms over 1-4 weeks, symptoms may be headache, vomiting, intermittent fever and reduced mental acuity are the early clinical features. Later progressive decrease in conscious level, double vision then blindness, and stroke-like features occur, with raised intracranial pressure. Occasionally patients have focal neurological features. Focal central nervous system lesions are more common in non-immunocompromised people who may also develop communicating hydrocephalus and frequently also have focal lung lesions.

1 million people are affected worldwide each year. Mostly AIDS-related. More common in sub-Saharan Africa and tropical countries (Brazil, Thailand, Malaysia, Papua New Guinea etc). In US, active population-based surveillance, conducted between 1992-1994, showed cryptococcosis developed in 2-5% of HIV-infected persons per annum.
Annual incidence has declined following widespread use of fluconazole and introduction of more effective combination antiretroviral treatment. Combined flucytosine and amphotericin B have now been shown to be the most effective treatment. Read more.

Among HIV-negative persons in US, average annual incidence  has remained almost constant at about 1 case per 100,000 population.

Skin lesion in patient with cryptococcal meningitis and disseminated infection.

Skin lesion in patient with cryptococcal meningitis and disseminated infection.